Home › Cancer (all types) › NCT07860801

Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer

CLEAR-AYA: Moving Beyond the Clouds - Pilot Study of Vaping Use Among AYA Patients With Cancer

Who can join

Ages 15 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Inclusion criteria for Patients:
* History of cancer diagnosis;
* Report vaping within the past 12 months as documented in the medical record, clinician note, and/or self-report;
* Age 15-39 years at date of consent;
* Receiving or have received treatment at MSK;
* Iidentify English as primary language as per medical record
* Inclusion criteria for Parents/Carebuddy (i.e., family member, friend):
* Self-report they are the parent/carebuddy of an AYA patient who currently or previously vaped.
* Inclusion criteria for Oncology Providers:
* Conducts ≥2 AYA clinical consultations weekly as per self-report or EMR;
* Is an MSK clinician (i.e., nurse practitioner, social worker, physician assistant, physician)

Exclusion Criteria:

* Exclusion criteria for Patients:
* Acute psychiatric symptoms impairing participation as per the EMR or as per clinician judgment;
* Reports exclusive use of combustible or smokeless tobacco products (i.e., no history of nicotine vaping).

About the study

The purpose of this study is to learn more about how adolescent and young adult (AYA) cancer patients, their parents and caregivers (referred to as a carebuddy in this study), and their healthcare providers think about and communicate around vaping and tobacco use. We hope this information will help us develop educational materials and provider training tools that are appropriate for young people with cancer.

A Community Advisory Board that is made up of AYA patients, parents/caregivers, and healthcare providers, is helping to guide the study. The board will review the materials, give feedback, help the study team understand the findings, and provides input to make sure the study is appropriate and practical for participants.

What is being tested

• Study assessments (other)

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 80 · Started: Sep 30, 2026

Contact the study team

• Gleneara Bates-Pappas, PhD, LMSW · Phone: 646-888-0158
• Smita Banerjee, PhD · Phone: 646-888-0011

Official record on ClinicalTrials.gov — NCT07860801

Locations in the U.S.

Conditions

• Cancer (all types)
• Vaping

From ClinicalTrials.gov, data retrieved Oct 7, 2026. Each study sets its own eligibility; the study team decides who can join.